Generex Oncology Granted United States Patent for AE37 Peptide Vaccine
14-Jul-2010 -
Generex Biotechnology Corporation announced that its wholly-owned subsidiary, Antigen Express, Inc., has been granted a United States patent on AE37, its lead immunotherapeutic vaccine. While Antigen Express has a strong intellectual property foundation on all Ii-Key technology, this is the ...
breast cancer
Generex Biotechnology
oncology
+2